Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 3420 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
BRIEF COMMUNICATION
Year : 2017  |  Volume : 21  |  Issue : 3  |  Page : 478-481

Choice of insulin in type 2 diabetes: A Southeast Asian perspective


1 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
2 Vietnamese Association of Diabetes and Endocrinology, Vietnam
3 Rajavithi Hospital, College of Medicine, Rangsit University, Ministry of Public Health, Bangkok, Thailand
4 Department of Endocrinology, Singapore General Hospital, Singapore
5 Universiti Sains Malaysia, Health Campus in Kelantan, Kelantan, Malaysia
6 Myanmar Diabetes Association, Yangon, Myanmar
7 Department of Medicine, University of Medicine 2, Yangon, Myanmar
8 BIRDEM Academy, Dhaka, Bangladesh
9 Department of Clinical Medicine, Diabetes Research Unit, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
10 Diabetology Unit, Preah Kossamak Hospital, Phnom Penh, Cambodia
11 Department of Medicine, Calmette Hospital, Phnom Penh, Cambodia
12 Center of Diabetes, Mahosot Hospital, Vientiane, Laos

Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital, Karnal, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijem.IJEM_82_17

Rights and Permissions

Southeast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs and requirements. From an insulin-centric viewpoint, the preparations prescribed in such pathways should be effective, safe, well tolerated, nonintrusive, and suitable for the use in multiple clinical situations including initiation and intensification. This brief communication describes the utility of premixed or dual action insulin in such clinical pathways and guidelines.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1016    
    Printed5    
    Emailed0    
    PDF Downloaded283    
    Comments [Add]    
    Cited by others 1    

Recommend this journal